文献速递心脑血管急症重症综合管理与镇静镇痛

SLANT评分预测心脏骤停昏迷幸存者的不良神经结局:一项回顾性队列的外部验证

The SLANT Score Predicts Poor Neurologic Outcome in Comatose Survivors of Cardiac Arrest: An External Validation Using a Retrospective Cohort.
PubMed 文献 · Neurocrit Care · 2022-07-28
一句话结论SLANT评分可能独立预测心脏骤停昏迷幸存者出院时不良神经结局(AUC 0.708,95%CI 0.536-0.879),但与院内死亡无显著关联;作者认为可将其纳入多模式预后评估。

本研究为回顾性队列外部验证,纳入本机构心脏骤停后昏迷、自主循环持续恢复并使用目标温度管理的幸存者,计算SLANT评分并按原始研究和Youden指数分析分层。主要结局为出院时不良神经结局(脑功能分级评分≥3),次要结局为院内死亡。SLANT高风险组与不良神经结局在单变量(p=0.005)和多变量分析(OR 1.162,95%CI 1.003-1.346,p=0.046)中显著相关,ROC曲线下面积0.708(95%CI 0.536-0.879,p=0.024)。SLANT评分与院内死亡无显著关联(p=0.064)。作者认为SLANT评分可能独立预测不良神经结局,纳入多模式评估可能提高预后判断准确性。

要点

  • SLANT高风险组与出院时不良神经结局(脑功能分级评分≥3)独立相关:多变量OR 1.162(95%CI 1.003-1.346,p=0.046)。
  • SLANT评分对不良神经结局的判别能力为中等:AUC 0.708(95%CI 0.536-0.879,p=0.024)。
  • SLANT评分与院内死亡无显著关联(p=0.064)。
  • 本队列中最常见的SLANT要素为初始不可电击心律(84.5%)和肾上腺素总剂量≥5 mg(63.9%)。
  • 作者认为将SLANT评分纳入多模式评估可能提高对心脏骤停昏迷幸存者的预后判断能力。

适用人群与场景

  • 本机构数据库中符合以下条件的心脏骤停幸存者:昏迷、自主循环持续恢复、使用目标温度管理,以与原始研究样本可比。

诊断标准与关键阈值

  • SLANT评分包含五项指标:初始不可电击心律、目标温度管理后白细胞计数、复苏期间肾上腺素总剂量、无旁观者心肺复苏、自主循环恢复时间。
  • 不良神经结局定义为出院时脑功能分级评分≥3。
  • 按原始研究和Youden指数分析两种方式将SLANT评分分为风险等级。

研究设计与关键结果

  • 研究设计:回顾性队列外部验证,查询本机构心脏骤停幸存者数据库,纳入昏迷、自主循环持续恢复并使用目标温度管理的患者。
  • 主要结局:SLANT高风险组与不良神经结局在单变量分析中显著相关(p=0.005),多变量分析OR 1.162(95%CI 1.003-1.346,p=0.046)。
  • 判别能力:ROC分析显示SLANT评分对不良神经结局为中等预后检验(AUC 0.708,95%CI 0.536-0.879,p=0.024)。
  • 次要结局:SLANT评分与院内死亡无显著关联(p=0.064)。
  • SLANT要素分布:初始不可电击心律84.5%,肾上腺素总剂量≥5 mg 63.9%。

证据类型、等级与局限

  • 证据类型:回顾性队列外部验证研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为SLANT评分可能独立预测不良神经结局,但不能预测院内死亡;将其纳入多模式评估可能提高对心脏骤停昏迷幸存者预后判断的准确性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Hypoxic brain injury is the leading cause of death in comatose patients following resuscitation from cardiac arrest. Neurological outcome can be difficult to prognosticate following resuscitation, and goals of care discussions are often informed by multiple prognostic tools. One tool that has shown promise is the SLANT score, which encompasses five metrics including initial nonshockable rhythm, leukocyte count after targeted temperature management, total adrenaline dose during resuscitation, lack of bystander cardiopulmonary resuscitation, and time to return of spontaneous circulation. This cohort study aimed to provide an external validation of this score by using a database of comatose cardiac arrest survivors from our institution.

METHODS: We retrospectively queried our database of cardiac arrest survivors, selecting for patients with coma, sustained return of spontaneous circulation, and use of targeted temperature management to have a comparable sample to the index study. We calculated SLANT scores for each patient and separated them into risk levels, both according to the original study and according to a Youden index analysis. The primary outcome was poor neurologic outcome (defined by a cerebral performance category score of 3 or greater at discharge), and the secondary outcome was in-hospital mortality. Univariable and multivariable analyses, as well as a receiver operator characteristic curve, were used to assess the SLANT score for independent predictability and diagnostic accuracy for poor outcomes.

RESULTS: We demonstrate significant association between a SLANT group with increased risk and poor neurologic outcome on univariable (p = 0.005) and multivariable analysis (odds ratio 1.162, 95% confidence interval 1.003-1.346, p = 0.046). A receiver operating characteristic analysis indicates that SLANT scoring is a fair prognostic test for poor neurologic outcome (area under the curve 0.708, 95% confidence interval 0.536-0.879, p = 0.024). Among this cohort, the most frequent SLANT elements were initial nonshockable rhythm (84.5%) and total adrenaline dose ≥ 5 mg (63.9%). There was no significant association between SLANT score and in-hospital mortality (p = 0.064).

CONCLUSIONS: The SLANT score may independently predict poor neurologic outcome but not in-hospital mortality. Including the SLANT score as part of a multimodal approach may improve our ability to accurately prognosticate comatose survivors of cardiac arrest.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Luck TG, Locke K, Sherman BC, et al. The SLANT Score Predicts Poor Neurologic Outcome in Comatose Survivors of Cardiac Arrest: An External Validation Using a Retrospective Cohort. Neurocrit Care. 2022. PMID: 35896769. doi:10.1007/s12028-022-01570-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。